Comparative Metabolic Characterization of Extraintestinal Pathogenic Escherichia coli Blood Isolates from Saudi Arabia

Background. The prevalence of bloodstream infections caused by extraintestinal pathogenic Escherichia coli (ExPEC) has increased substantially. E. coli ST131 is one of the dominant ExPEC clones among E. coli bacteremia population. Metabolism can trigger the pathogenesis of some bacterial isolates, a...

Full description

Saved in:
Bibliographic Details
Main Authors: Abdulaziz Alangari, Ahmad Abu Jaffal, Abdulaziz M. Alyousef, Abdullah A. Alyousef
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of Tropical Medicine
Online Access:http://dx.doi.org/10.1155/2022/1745835
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850120787584876544
author Abdulaziz Alangari
Ahmad Abu Jaffal
Abdulaziz M. Alyousef
Abdullah A. Alyousef
author_facet Abdulaziz Alangari
Ahmad Abu Jaffal
Abdulaziz M. Alyousef
Abdullah A. Alyousef
author_sort Abdulaziz Alangari
collection DOAJ
description Background. The prevalence of bloodstream infections caused by extraintestinal pathogenic Escherichia coli (ExPEC) has increased substantially. E. coli ST131 is one of the dominant ExPEC clones among E. coli bacteremia population. Metabolism can trigger the pathogenesis of some bacterial isolates, and here we evaluated and compared the metabolic traits of E. coli bacteremia isolates including β-lactamase (BL)/extended-spectrum β-lactamase (ESBL)-positive and ESBL-negative isolates and ST131 and non-ST131 isolates. Methods. The metabolic profiles of thirty E. coli isolates, obtained from blood samples for hospitalized individuals at a tertiary healthcare facility in Riyadh, were determined using HiMedia carbohydrate test strips. The difference in the utilization ability between isolate groups was then statistically assessed. Results. Our data found that non-BL/ESBL producers were of low metabolic capacity compared with ESBL-positive isolates although the difference remained insignificant. Higher levels of utilization for some carbohydrates, such as fructose and trehalose, were detected among ST131 isolates when compared with non-ST131, and ST131 was also significantly associated with metabolizing rhamnose. The mean bio-score of both isolate groups was insignificant. We showed no link between metabolism and antimicrobial susceptibility profiles among tested blood isolates. Conclusion. ST131 blood isolates were slightly higher in their carbohydrate utilization activity than non-ST131. More importantly, ST131 isolates were significantly capable of metabolizing rhamnose. Future research should focus on the factors that might drive the success of major ExPEC clones such as ST131.
format Article
id doaj-art-62fa2a3bc3454aa9a5407b05a9bde4da
institution OA Journals
issn 1687-9694
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Journal of Tropical Medicine
spelling doaj-art-62fa2a3bc3454aa9a5407b05a9bde4da2025-08-20T02:35:16ZengWileyJournal of Tropical Medicine1687-96942022-01-01202210.1155/2022/1745835Comparative Metabolic Characterization of Extraintestinal Pathogenic Escherichia coli Blood Isolates from Saudi ArabiaAbdulaziz Alangari0Ahmad Abu Jaffal1Abdulaziz M. Alyousef2Abdullah A. Alyousef3Department of Clinical Laboratory SciencesDepartment of Clinical Laboratory SciencesDepartment of Medical AffairsDepartment of Clinical Laboratory SciencesBackground. The prevalence of bloodstream infections caused by extraintestinal pathogenic Escherichia coli (ExPEC) has increased substantially. E. coli ST131 is one of the dominant ExPEC clones among E. coli bacteremia population. Metabolism can trigger the pathogenesis of some bacterial isolates, and here we evaluated and compared the metabolic traits of E. coli bacteremia isolates including β-lactamase (BL)/extended-spectrum β-lactamase (ESBL)-positive and ESBL-negative isolates and ST131 and non-ST131 isolates. Methods. The metabolic profiles of thirty E. coli isolates, obtained from blood samples for hospitalized individuals at a tertiary healthcare facility in Riyadh, were determined using HiMedia carbohydrate test strips. The difference in the utilization ability between isolate groups was then statistically assessed. Results. Our data found that non-BL/ESBL producers were of low metabolic capacity compared with ESBL-positive isolates although the difference remained insignificant. Higher levels of utilization for some carbohydrates, such as fructose and trehalose, were detected among ST131 isolates when compared with non-ST131, and ST131 was also significantly associated with metabolizing rhamnose. The mean bio-score of both isolate groups was insignificant. We showed no link between metabolism and antimicrobial susceptibility profiles among tested blood isolates. Conclusion. ST131 blood isolates were slightly higher in their carbohydrate utilization activity than non-ST131. More importantly, ST131 isolates were significantly capable of metabolizing rhamnose. Future research should focus on the factors that might drive the success of major ExPEC clones such as ST131.http://dx.doi.org/10.1155/2022/1745835
spellingShingle Abdulaziz Alangari
Ahmad Abu Jaffal
Abdulaziz M. Alyousef
Abdullah A. Alyousef
Comparative Metabolic Characterization of Extraintestinal Pathogenic Escherichia coli Blood Isolates from Saudi Arabia
Journal of Tropical Medicine
title Comparative Metabolic Characterization of Extraintestinal Pathogenic Escherichia coli Blood Isolates from Saudi Arabia
title_full Comparative Metabolic Characterization of Extraintestinal Pathogenic Escherichia coli Blood Isolates from Saudi Arabia
title_fullStr Comparative Metabolic Characterization of Extraintestinal Pathogenic Escherichia coli Blood Isolates from Saudi Arabia
title_full_unstemmed Comparative Metabolic Characterization of Extraintestinal Pathogenic Escherichia coli Blood Isolates from Saudi Arabia
title_short Comparative Metabolic Characterization of Extraintestinal Pathogenic Escherichia coli Blood Isolates from Saudi Arabia
title_sort comparative metabolic characterization of extraintestinal pathogenic escherichia coli blood isolates from saudi arabia
url http://dx.doi.org/10.1155/2022/1745835
work_keys_str_mv AT abdulazizalangari comparativemetaboliccharacterizationofextraintestinalpathogenicescherichiacolibloodisolatesfromsaudiarabia
AT ahmadabujaffal comparativemetaboliccharacterizationofextraintestinalpathogenicescherichiacolibloodisolatesfromsaudiarabia
AT abdulazizmalyousef comparativemetaboliccharacterizationofextraintestinalpathogenicescherichiacolibloodisolatesfromsaudiarabia
AT abdullahaalyousef comparativemetaboliccharacterizationofextraintestinalpathogenicescherichiacolibloodisolatesfromsaudiarabia